Used CTCAE v4.0 for iOS?


CTCAE v4.0 Analysis

AI Assisted Content ·

Not written by CNET Staff.

CTCAE v4.0 is a free educational application designed for iPhone users, focusing on health and fitness. This app serves as a resource for healthcare professionals, providing detailed information on the Common Terminology Criteria for Adverse Events (CTCAE), which is essential for understanding and documenting adverse effects in clinical trials. The app's user-friendly interface allows for easy navigation through various categories of adverse events, making it an invaluable tool for oncologists and other medical professionals.

Top Recommended Alternative

The application includes a comprehensive database that categorizes adverse events by severity and provides clear definitions, helping users to accurately assess and report patient experiences. With features such as search functionality and the ability to filter events, CTCAE v4.0 streamlines the process of finding relevant information quickly. This app is particularly useful in enhancing the quality of patient care and ensuring compliance with clinical standards.

Enlarged image for CTCAE v4.0
CTCAE v4.0 0/1

Used CTCAE v4.0 for iOS?


Explore More


Full Specifications

GENERAL
Release
Latest update
Version
1.1
OPERATING SYSTEMS
Platform
iOS
Operating System
iOS 12.1.2
Additional Requirements
Compatible with iPhone, iPod Touch, and iPad. Requires iOS 3.1 or later. iTunes account required
POPULARITY
Total Downloads
290
Downloads Last Week
0

Report Software

Last Updated


Developer’s Description

The National Cancer Institute (NCI) Common Terminology Criteria for Adverse Events (CTCAE) is a standardized system to quantify or grade the...

Download.com
Your review for CTCAE v4.0
Download.com

AI Assisted Content Disclosure

Content created and reviewed by Softonic with information obtained from The Children's Hospital of Philadelphia, using AI.

CNET's editorial team was not involved in the creation of this content. Opinions, analysis and reviews were not provided by CNET.